Page 850 - Phase News Today

VICTORIA International Container Terminal (VICT), the International Container Terminal Services Inc. (ICTSI) operation at the Port of Melbourne in Australia, is expected to complete Phase 3A of its expansion project at the end of the year.

Vice President Kamala Harris will tackle two delicate tasks this weekend in Dubai: she’ll try to demonstrate US environmental leadership despite President...

Phase 3b DAYLIGHT study being presented at ESG 2023 demonstrated fezolinetant 45 mg achieved statistically significant reductions in the frequency and severity of moderate to severe vasomotor symptoms due to menopause and patient-reported sleep disturbance at 24 weeks Women considered unsuitable included those with contraindications, who are averse to taking, have stopped taking or have conditions that suggest caution in using hormone therapy Results will support health technology a...

A contractor is being sought to complete stage two of the Whanganui Port redevelopment - the rebuild of wharf two - with dredging equipment also being...

Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

DUBAI (Kyodo) -- Prime Minister Fumio Kishida pledged Friday to take necessary measures to reduce Japan's reliance on coal-fired power generation

Ludhiana: MC commissioner Sandeep Rishi visited the civic body’s main dump site on Tajpur Road and reviewed work on bio-remediation of legacy waste on.

Pti: Positive results from Phase 2A clinical trial of TBA-7371, a new drug candidate for tuberculosis

Almost two years since the infamous shooting of 10 robbery suspects at Phase 2 location in Gaborone, the police are now left to pay maintenance costs for the house where the incident took place. According to recently released Government Gazette the police will now have to bear the costs of maintaining the house

Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.